Initial Choice of Antihypertensive on Long-Term Cardiovascular Outcomes in CKD | Zendy

Adam WhaleyConnell | Zendy; James R. Sowers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Initial Choice of Antihypertensive on Long-Term Cardiovascular Outcomes in CKD

Author(s) -

Adam WhaleyConnell,

James R. Sowers

Publication year - 2012

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04130412

Subject(s) - medicine , amlodipine , lisinopril , kidney disease , heart failure , diabetes mellitus , chlorthalidone , context (archaeology) , cohort , population , cardiology , blood pressure , myocardial infarction , disease , stroke (engine) , intensive care medicine , endocrinology , angiotensin converting enzyme , mechanical engineering , paleontology , environmental health , biology , engineering

Hypertension contributes substantially to the risk for long-term cardiovascular disease (CVD) outcomes such as stroke, ischemic heart disease, and heart failure, especially in persons with CKD ([1][1]). In this regard, BP reduction is an important CVD risk reduction strategy, especially in persons

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research